Cashu Finance
  • Terminal
  • Stocks
  • Spotlight
  • Research
Log inSign Up
  1. Stocks
  2. Healthcare
  3. NASDAQ
  4. ALMS

Market Cap: $1.13B

AI

Alumis Inc.

ALMS
NASDAQUSD
Purchase ALMS
OverviewNewsAnalyst ReportsFinancialsPolitician TradesInsider TradesExecutivePatentsEarnings Surprise
Cashu Finance

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

StocksAboutAdvertisersBrokersContact

Legal

Terms of ServicePrivacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Executive

Martin Babler

President, Chief Executive Officer & Chairman

Compensation
$1,205,069
John R. Schroer

Chief Financial Officer

Compensation
Compensation not disclosed
Sanam Pangali

Chief Legal Officer & Corporate Secretary

Compensation
Compensation not disclosed
Claire Langrish

Senior Vice President & Head of Immunology and Translational Science

Compensation
Compensation not disclosed
Grace Halteh

Senior Vice President & Head of Quality and Regulatory

Compensation
Compensation not disclosed
Kolbot By

Senior Vice President & Head of Technical Operations

Compensation
Compensation not disclosed
Philip Nunn

Senior Vice President of Pharmacology & Project Team Leader

Compensation
Compensation not disclosed
David Goldstein

Chief Scientific Officer

Compensation
$821,186
Jack Danilkowicz

Chief Commercial Officer

Compensation
Compensation not disclosed
Jorn Drappa

Chief Medical Officer & Head of Research and Development

Compensation
$817,058
Mark Bradley

Chief Development Officer

Compensation
Compensation not disclosed
Roy C. Hardiman

Chief Business & Strategy Officer

Compensation
$619,841